A study by Kang and colleagues also demonstrated that high grade serous ovarian cancer patients with GOF mutant p53 frequently showed resistance against platinum-based treatment and were prone to distant metastasis [25]. The gene discussed is TP53; the disease is ovarian serous adenocarcinoma.